Biotech: Pressemitteilungen - Kategorie - Seite 52

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Genetic Technologies Announces Publication of Key Scientific Validation Results in Support of BREVAGenplus(R)

MELBOURNE, AUSTRALIA: MELBOURNE, AUSTRALIA -- (Marketwired) -- 12/21/15 -- Molecular diagnostics company Genetic Technologies Limited (ASX: GTG) (NASDAQ: GENE) ("Company") announced today the publication of a ne ...

Threshold Pharmaceuticals Announces Workforce Reduction

SOUTH SAN FRANCISCO, CA: Threshold to Focus on Clinical Trials of Tarloxotinib While Evaluating Potential Further Development of Evofosfamide and Other Strategic Options for the Company ...

Vista Partners Updates Coverage on Soligenix, Inc. (Ticker: SNGX); Price Target $7.00

SAN FRANCISCO, CA: SAN FRANCISCO, CA -- (Marketwired) -- 12/18/15 -- announced today that it has updated coverage on Soligenix, Inc. ("The Company" or "SNGX") (OTCBB: SNGX), a clinical stage biopha ...

Trunity Announces Planned Name Change and Further Information on Restructuring

ATLANTA, GA: ATLANTA, GA -- (Marketwired) -- 12/17/15 -- Trunity Holdings, Inc. (OTCBB: TNTY) (OTCQB: TNTY) made further announcements regarding its restructuring plan today, including its plans to change the nam ...

West Announces Quarterly Dividend and Share Repurchase Program

EXTON, PA: EXTON, PA -- (Marketwired) -- 12/17/15 -- West Pharmaceutical Services, Inc. (NYSE: WST) today announced that the Company's Board of Directors has approved a first-quarter 2016 dividend of $0.12 ...

IBEX Reports First Quarter Fiscal 2016 Results

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 12/17/15 -- IBEX Technologies Inc. ("IBEX" or the "Company") (TSX VENTURE: IBT) today reported its financial results for the quarter ended Oc ...

RepliCel Announces Completion of First Injections in Clinical Trial of RCS-01 for Skin Aging and UV-Damaged Skin

VANCOUVER, BRITISH COLUMBIA: Phase 1 clinical trial investigating the use of a patient-specific cell-based dermal rejuvenation product (RCS-01) is scheduled to deliver data in late 2016 ...

Immunovaccine Publishes Findings Unique to DepoVax(TM) Technology on Potential of MRI Scans to Predict and Optimize Cancer Vaccine Response

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 12/17/15 -- Immunovaccine Inc. ("Immunovaccine" or the "Company") (TSX: IMV)(OTCQX: IMMVF), a clinical stage vaccine and immunotherapy com ...

Online Disruptive Technologies Announces Approval to Perform Diagnostic Clinical Trials on Human Blood

LAS VEGAS, NEVADA: LAS VEGAS, NEVADA -- (Marketwired) -- 12/16/15 -- Online Disruptive Technologies, Inc. (OTC PINK: ONDR) (the "Company") is pleased to announce that its majority owned Israeli subsidiary, S ...

RepliCel Life Sciences Announces Leadership Transition

VANCOUVER, BRITISH COLUMBIA: Lee Buckler, former VP Business & Corporate Development, appointed CEO President & Director; David Hall retires as CEO and named Board Chairman ...

Med BioGene Inc. Announces Commercialization Status of GeneFX Lung(R)

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/15/15 -- Med BioGene Inc. (the "Company") (TSX VENTURE: MBI) is very pleased to be able to confirm that our licensee, Helomics™ has adv ...

Novimmune Abstract Selected for the "Best of ASH" at the 2015 Annual Meeting of the American Society of Hematology (ASH)

GENEVA, SWITZERLAND: The Abstract Presented Data on NI-0501, an Experimental Drug for the Treatment of Hemophagocytic Lymphohistiocytosis (HLH) ...

Soricimed Completes Phase 1 Trial of SOR-C13 in Advanced Solid Tumour Cancers

MONCTON, NEW BRUNSWICK: MONCTON, NEW BRUNSWICK -- (Marketwired) -- 12/15/15 -- Soricimed Biopharma Inc. (""), a clinical-stage pharmaceutical company discovering and developing peptide-based cancer therapeutics, t ...

M Pharmaceutical Announces Change to Board of Directors and Management

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 12/15/15 -- M Pharmaceutical, Inc. (CSE: MQ)(OTCQB: MPHMF)(FRANKFURT: T3F2), (the "Company" or "M Pharma"), announced that Martin ...

MedMira Reports Fiscal First Quarter 2016 Financial Results

HALIFAX, NOVA SCOTIA: HALIFAX, NOVA SCOTIA -- (Marketwired) -- 12/14/15 -- MedMira Inc. (MedMira) (TSX VENTURE: MIR), reported today on its financial results for the three month period ending October 31, 2015. The Company ...

Medifocus, Inc. Announces Closing of First Tranche of Units Offering

COLUMBIA, MD and TORONTO, ON: COLUMBIA, MD and TORONTO, ON -- (Marketwired) -- 12/14/15 -- Medifocus Inc. (TSX VENTURE: MFS) (OTCQX: MDFZF) ("Medifocus" or the "Company") announces that it has completed the fi ...

Corcept Therapeutics Announces Initial Efficacy Results in Phase 1/2 Trial of Mifepristone in Combination With Eribulin for the Treatment of Patients With Metastatic Triple-Negative Breast Cancer

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 12/14/15 -- Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, development and commercialization of drugs that tre ...

Entolimod Shown to Suppress Liver Metastases in Model of Ocular Melanoma in Collaborative Study by Cleveland BioLabs, Emory University and Roswell Park Cancer Institute

BUFFALO, NY: BUFFALO, NY -- (Marketwired) -- 12/14/15 -- (NASDAQ: CBLI)and today announced the publication of a study in Oncotarget demonstrating the ability of entolimod to suppress liver metastases in a preclin ...


Seite 52 von 255:  « ..  51 52 53  54  55  56  57  58  59  60  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z